Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
25.89
+0.69 (2.74%)
At close: Apr 29, 2026

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 2021 - 2017
Market Capitalization
10,2739,9205,38510,392--
Upgrade
Market Cap Growth
82.29%84.22%-48.18%---
Upgrade
Enterprise Value
9,2039,2034,0688,758--
Upgrade
Last Close Price
25.8925.0013.5025.83--
Upgrade
PE Ratio
86.3383.33104.64119.22--
Upgrade
PS Ratio
5.305.123.045.06--
Upgrade
PB Ratio
2.302.231.242.38--
Upgrade
P/TBV Ratio
2.402.321.292.49--
Upgrade
P/OCF Ratio
---294.81--
Upgrade
EV/Sales Ratio
4.754.752.304.26--
Upgrade
EV/EBITDA Ratio
23.9124.2219.1039.79--
Upgrade
EV/EBIT Ratio
51.5851.58115.30136.98--
Upgrade
Debt / Equity Ratio
0.120.120.090.080.210.05
Upgrade
Debt / EBITDA Ratio
1.381.381.751.581.240.18
Upgrade
Net Debt / Equity Ratio
-0.24-0.24-0.38-0.42-0.02-0.02
Upgrade
Net Debt / EBITDA Ratio
-2.81-2.81-7.75-8.32-0.15-0.09
Upgrade
Net Debt / FCF Ratio
3.143.149.384.170.180.66
Upgrade
Asset Turnover
0.320.320.310.430.650.75
Upgrade
Inventory Turnover
5.345.346.886.674.402.89
Upgrade
Quick Ratio
2.062.062.353.200.931.01
Upgrade
Current Ratio
2.662.662.683.501.261.67
Upgrade
Return on Equity (ROE)
2.67%2.67%1.18%2.69%22.93%34.51%
Upgrade
Return on Assets (ROA)
1.86%1.86%0.38%0.84%5.18%10.62%
Upgrade
Return on Invested Capital (ROIC)
4.11%4.72%1.16%2.46%12.86%23.80%
Upgrade
Return on Capital Employed (ROCE)
3.60%3.60%0.80%1.40%10.20%19.60%
Upgrade
Earnings Yield
1.16%1.20%0.96%0.84%--
Upgrade
FCF Yield
-3.32%-3.44%-3.27%-4.23%--
Upgrade
Dividend Yield
0.12%-0.22%0.19%--
Upgrade
Payout Ratio
23.58%23.58%59.97%61.72%3.44%0.45%
Upgrade
Buyback Yield / Dilution
0.42%0.42%-2.71%-10.02%0.00%-0.13%
Upgrade
Total Shareholder Return
0.54%0.42%-2.49%-9.83%0.00%-0.13%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.